Efficacy, Tolerance, and Plasma Levels of Abiraterone and Its Main Metabolites in a Patient With Metastatic Castration-resistant Prostate Cancer With a Hepatic Transplant.
Merel van Nuland
,
Julie M Janssen
,
Bart van Hoek
,
Hilde Rosing
,
Jos H Beijnen
,
André M Bergman
More about this publication
Clinical genitourinary cancer
Volume
17
Issue nr.
5
Pages
e893-e896
Publication date
01-10-2019
Full text links
Publisher website (DOI)
10.1016/j.clgc.2019.05.026
Europe PubMed Central
31248829
Pubmed
31248829